These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3896683)

  • 1. Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
    Kim KS
    Chemotherapy; 1985; 31(4):304-9. PubMed ID: 3896683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis.
    Kim KS; Hang JH; Bayer AS
    Chemotherapy; 1987; 33(3):177-82. PubMed ID: 2954777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats.
    Delaplane D; Yogev R; Shulman ST
    J Antimicrob Chemother; 1983 Jan; 11(1):69-73. PubMed ID: 6298176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis.
    Kim KS
    J Antimicrob Chemother; 1986 Feb; 17(2):239-44. PubMed ID: 3516964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
    Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria.
    Kim KS
    J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.
    Tischhauser G; Kayser FH
    Infection; 1983; 11(4):219-26. PubMed ID: 6578202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
    Kim KS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):289-93. PubMed ID: 3087277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse during penicillin treatment of group B streptococcal meningitis.
    Dorand RD; Adams G
    J Pediatr; 1976 Aug; 89(2):188-90. PubMed ID: 781198
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal group B streptococcal bacteremia and meningitis.
    Smith AJ; Cunha BA
    Heart Lung; 1989 Jan; 18(1):94-6. PubMed ID: 2643591
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of group B III streptococcal meningitis.
    Walker SH; Santos AQ; Quintero BA
    J Pediatr; 1976 Aug; 89(2):187-8. PubMed ID: 781197
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.
    Ferrieri P; Burke B; Nelson J
    Infect Immun; 1980 Mar; 27(3):1023-32. PubMed ID: 6991426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis.
    Patamasucon P; McCracken GH
    Antimicrob Agents Chemother; 1982 Mar; 21(3):390-2. PubMed ID: 7049073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III group B streptococcal infections in mice: bacteremia and meningitis following oral inoculation.
    Lounsbery JL; Green LR; Furtado D
    Can J Microbiol; 1981 Nov; 27(11):1150-5. PubMed ID: 7032679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent group B streptococcal infection. Case report.
    Barton LL; Kapoor NK
    Clin Pediatr (Phila); 1982 Feb; 21(2):100-1. PubMed ID: 7035047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.